Literature DB >> 4583980

Synthesis of antihemophilic factor antigen by cultured human endothelial cells.

E A Jaffe, L W Hoyer, R L Nachman.   

Abstract

Antihemophilic factor (AHF, Factor VIII) antigen has been demonstrated in cultured human endothelial cells by immunofluorescence studies using monospecific rabbit antibody to human AHF. Control studies with cultured human smooth muscle cells and human fibroblasts were negative. By radioimmunoassay it was demonstrated that cultured human endothelial cells contain AHF antigen which is released into the culture medium. Cultured smooth muscle cells and fibroblasts did not have this property. Cultured endothelial cells incorporated radioactive amino acids into high molecular weight, AHF antigen-rich protein fractions prepared from the culture media, 7% of the radioactive amino acid counts incorporated into this material were precipitated by globulin prepared from rabbit anti-AHF whereas normal rabbit globulin precipitated only 1.5% of the counts. Although cultured endothelial cells actively synthesize AHF antigen, AHF procoagulant activity was not detected in the culture medium. Studies seeking a basis for the lack of procoagulant activity have not clarified this deficiency, but they have established that exogenous AHF procoagulant activity is not inactivated by the tissue culture system.

Entities:  

Mesh:

Substances:

Year:  1973        PMID: 4583980      PMCID: PMC302543          DOI: 10.1172/JCI107471

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  29 in total

1.  Conditions influencing the stability of human antihaemophilic factor.

Authors:  R A KEKWICK; P L WALTON
Journal:  Nature       Date:  1962-06-02       Impact factor: 49.962

2.  Congenital disorders of the mechanism for coagulation of blood.

Authors:  P DIDISHEIM; J H LEWIS
Journal:  Pediatrics       Date:  1958-09       Impact factor: 7.124

3.  Factor 8 on the vascular intima: possible importance in haemostasis and thrombosis.

Authors:  A L Bloom; J C Giddings; C J Wilks
Journal:  Nat New Biol       Date:  1973-02-14

4.  Formation of intrinsic factor-X activator activity, with special reference to the role of thrombin.

Authors:  B Osterud; S I Rapaport; S Schiffman; M M Chong
Journal:  Br J Haematol       Date:  1971-12       Impact factor: 6.998

5.  Isolation and characterization of human Factor VIII (antihemophilic factor).

Authors:  M E Legaz; G Schmer; R B Counts; E W Davie
Journal:  J Biol Chem       Date:  1973-06-10       Impact factor: 5.157

Review 6.  The development of hemostasis in the human fetus and newborn infant.

Authors:  W A Bleyer; N Hakami; T H Shepard
Journal:  J Pediatr       Date:  1971-11       Impact factor: 4.406

7.  Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen.

Authors:  L W Hoyer
Journal:  J Lab Clin Med       Date:  1972-12

8.  Antihemophilic factor release by perfused liver and spleen: relationship to hemophilia.

Authors:  J C Norman; J P Lambilliotte; Y Kojima; H S Sise
Journal:  Science       Date:  1967-11       Impact factor: 47.728

9.  Separation of sub-units of antihemophilic factor (AHF) by agarose gel chromatography.

Authors:  H J Weiss; L L Phillips; W Rosner
Journal:  Thromb Diath Haemorrh       Date:  1972-04-30

10.  Immunologic differentiation of classic hemophilia (factor 8 deficiency) and von Willebrand's dissase, with observations on combined deficiencies of antihemophilic factor and proaccelerin (factor V) and on an acquired circulating anticoagulant against antihemophilic factor.

Authors:  T S Zimmerman; O D Ratnoff; A E Powell
Journal:  J Clin Invest       Date:  1971-01       Impact factor: 14.808

View more
  282 in total

1.  The effects of epinephrine infusion in patients with von Willebrand's disease.

Authors:  F R Rickles; L W Hoyer; M E Rick; D J Ahr
Journal:  J Clin Invest       Date:  1976-06       Impact factor: 14.808

2.  Von Willebrand's disease.

Authors: 
Journal:  Br Med J       Date:  1976-09-25

3.  Subunit structure of factor VIII antigen synthesized by cultured human endothelial cells.

Authors:  E A Jaffe; R L Nachman
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

4.  Correction of a murine model of von Willebrand disease by gene transfer.

Authors:  Robert G Pergolizzi; Guangchun Jin; Diane Chan; Lorraine Pierre; James Bussel; Barbara Ferris; Philip L Leopold; Ronald G Crystal
Journal:  Blood       Date:  2006-04-25       Impact factor: 22.113

5.  Effect of temperature on in vitro proliferative activity of human umbilical vein endothelial cells.

Authors:  Q R Yang; D V Berghe
Journal:  Experientia       Date:  1995-02-15

6.  Plasmodium falciparum malaria. An amelanotic melanoma cell line bears receptors for the knob ligand on infected erythrocytes.

Authors:  J A Schmidt; I J Udeinya; J H Leech; R J Hay; M Aikawa; J Barnwell; I Green; L H Miller
Journal:  J Clin Invest       Date:  1982-08       Impact factor: 14.808

7.  Monoclonal antibodies specific for human monocytes, granulocytes and endothelium.

Authors:  N Hogg; S MacDonald; M Slusarenko; P C Beverley
Journal:  Immunology       Date:  1984-12       Impact factor: 7.397

8.  Immunohistochemical localisation of factor VIII-related antigen in Hodgkin's disease.

Authors:  J Crocker; P J Smith
Journal:  J Clin Pathol       Date:  1984-01       Impact factor: 3.411

9.  Rickettsial interactions with human endothelial cells in vitro: adherence and entry.

Authors:  T S Walker
Journal:  Infect Immun       Date:  1984-05       Impact factor: 3.441

10.  A coagulation pathway on bovine aortic segments leading to generation of Factor Xa and thrombin.

Authors:  D M Stern; P P Nawroth; W Kisiel; D Handley; M Drillings; J Bartos
Journal:  J Clin Invest       Date:  1984-12       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.